4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000018
Chief Executive Officer acquired 2,224 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hackman Jeffrey S. · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-12 | Grant or award : show line 1 in the form | +2,224 | $5.53 | $12,299 | 69,685 | D |
Loading xslF345X06/form4-10132026_041008.xml…